Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Kits > EGF R > CAA-B005

Recombinant Monoclonal Anti-EGFR Antibody, Rabbit (5A6), Ready-To-Use

For research use only.

Order Now

  • Product Overview
    Receptor tyrosine kinase binding ligands of the EGF family and activating several signaling cascades to convert extracellular cues into appropriate cellular responses. The EGFR IHC 5A6 Kit is a quick assay to detect EGFR across tumors to identify patients eligible for multiple targeted therapies. Kit product are manufactured in a dedicated GMP facility and are compliant with our ISO 13485 quality management system.
  • Product Specifications
    AnalyteEGFR
    Format7.5ml
    ReactivityHuman
    SpeciesRabbit
    Regulatory StatusRUO
    Applicable PlatformLEICA BOND III
  • Materials Provided

    Recombinant Monoclonal Anti-EGFR Antibody, Rabbit (5A6)

  • Application

    The kit is developed for use in the EGFR protein in the formalin-fixed, paraffin-embedded tissue. It is indicated as an aid in the assessment of EGFR expression in human tissues.

  • State

    Liquid

  • Storage

    Stored at 2°C to 8°C.The shelf life is 30 days from the date of opening.

Control Sample
 EGF R CONTROL SAMPLE

Use ACRO EGFR 5A6 kit to stain human tonsil tissue, positive cell membrane specific positive staining (staining intensity ≥ 1), no non-specific staining (staining intensity < 1) , no background staining (staining intensity < 1 ).

Cancer Sample
Extensibility

ACRO EGFR 5A6 kit expandable test: colorectal cancer, gastric cancer, pancreatic cancer and cervical cancer.

 EGF R EXTENSIBILITY EGF R EXTENSIBILITY

Use EGFR 5A6 kit to stain colorectal cancer, gastric cancer, pancreatic cancer and cervical cancer. tissue samples respectively.

  • Clinical and Translational Updates

Comments (0)


ETA of in-stock products: 2 business days

Price(USD) : $1540.00

Promotion & Exhibitions



Drug Development Status

  • Number of Launched Drugs:33 Details
  • Number of Drugs in Clinical Trials:182 Details
  • Latest Research Phase:Approved

Datasheet & Documentation

Request for DMF
DMF (Drug Master File)

Related Products

New Product Launch

Questions & Comments

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message